TEISHIMA, Jun et al. Impact of the systemic immune-inflammation index for the prediction of prognosis and modification of the risk model in patients with metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitors. Canadian Urological Association Journal, [S. l.], v. 14, n. 11, p. E582–7, 2020. DOI: 10.5489/cuaj.6413. Disponível em: https://cuaj.ca/index.php/journal/article/view/6413. Acesso em: 27 apr. 2026.